Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04416568
Title Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute

kidney rhabdoid cancer

Advanced Solid Tumor

atypical teratoid rhabdoid tumor

epithelioid sarcoma

central nervous system cancer


rhabdoid cancer


Ipilimumab + Nivolumab

Age Groups: adult | child
Covered Countries USA

No variant requirements are available.